Dumayo, William B.

HRN: 09-87-17  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/19/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/19/2022
10/26/2022
IV INFUSION
4.5g
Q6
Elevated WBC, CVA Tenderness, Fever
Waiting Final Action 
10/21/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/21/2022
10/25/2022
IVT
2.25g
Q8
UTI; CAP MR
Waiting Final Action 
08/08/2023
CEFTRIAXONE 1G (VIAL)
08/08/2023
08/14/2023
IVT
2g
OD
CAP MR
Waiting Final Action 
08/08/2023
AZITHROMYCIN 500MG TABLET (TAB)
08/08/2023
08/12/2023
ORAL
500mg
OD
CAP MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: